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AbstrAct
Objectives the epidemiology of distal arm pain and 
back pain are similar. However, management differs 
considerably: for back pain, rest is discouraged, whereas 
patients with distal arm pain are commonly advised to 
rest and referred to physiotherapy. We hypothesised 
that remaining active would reduce long-term disability 
and that fast-track physiotherapy would be superior to 
physiotherapy after time on a waiting list.
Methods adults referred to community-based 
physiotherapy with distal arm pain were randomised to: 
advice to remain active while awaiting physiotherapy 
(typically delivered after 6–8 weeks); advice to rest while 
awaiting physiotherapy, or immediate treatment. intention-
to-treat analysis determined whether the probability of 
recovery at 26 weeks was greater among the active 
advice group, compared with those advised to rest and/
or among those receiving immediate versus usually timed 
physiotherapy.
Results 538 of 1663 patients invited between February 
2012 and February 2014 were randomised (active=178; 
rest=182; immediate physiotherapy=178). 81% provided 
primary outcome data, and complete recovery was 
reported by 60 (44%), 46 (32%) and 53 (35%). those 
advised to rest experienced a lower probability of recovery 
(Or: 0.54; 95% ci 0.32 to 0.90) versus advice to remain 
active. However, there was no benefit of immediate 
physiotherapy (0.64; 95% ci 0.39 to 1.07).
Conclusions among patients awaiting physiotherapy for 
distal arm pain, advice to remain active results in better 
26-week functional outcome, compared with advice to 
rest. also, immediate physiotherapy confers no additional 
benefit in terms of disability, compared with physiotherapy 
delivered after 6–8 weeks waiting time. these findings 
question current guidance for the management of distal 
arm pain.
InTROduCTIOn
Upper limb pain is common among work-
ing-aged adults: one UK study demonstrated a 
1-year period prevalence of pain lasting >1 day 
of 48%, among whom one-third had sought 
healthcare.1 The UK Health and Safety Exec-
utive estimated that 4 million working days 
were lost because of work-related upper limb 
disorders in Great Britain in 2016/2017.2 
However, epidemiological investigations have 
been hampered by the lack of an agreed 
classification for upper limb disorders and 
the plethora of tautological terms implying 
causation including ‘repetitive strain injury’, 
Key messages
What is already known about this subject?
 ► the epidemiology and prognosis of distal arm pain 
and low back pain are similar. Management of the 
two conditions differs markedly – rest is not recom-
mended for low back pain but is commonly advocat-
ed for persons with distal arm pain.
 ► We hypothesised that, in patients awaiting physio-
therapy for distal arm pain, advice to remain active 
would result in superior functional recovery com-
pared with advice to rest.
What does this study add?
 ► this is the first trial to compare the effectiveness 
of advice to maintain activity, versus advice to rest, 
among patients with distal arm pain. advice to re-
main active results in better functional outcome at 
26wks, compared with advice to rest.
 ► in addition, immediate physiotherapy confers no ad-
ditional benefit in terms of disability, compared to 
physiotherapy delivered after 6-8wks.
How might this impact on clinical practice?
 ► the current study questions current guidance for 
the management of distal arm pain. these findings 
show that the ‘keep active’ management approach 
long advocated for low back pain has parallels in 
other regional musculoskeletal pain conditions.
 ► the current results also suggest that, for distal arm 
pain, early clinical intervention is not necessarily as-
sociated with improved outcome.
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‘occupational cervicobrachial disorders’ and ‘work-related 
upper limb disorders’. More recently, with more consensus 
over case definitions,3 4 epidemiological studies of distal 
arm pain have found that both mechanical exposures 
(carrying weights, working with hands above shoulder 
height, bending/straightening the elbow, repetitive move-
ments of the hand/wrist) and psychosocial factors (lack of 
job control, monotonous work, job dissatisfaction, negative 
beliefs, low expectation of recovery) were associated.5 6
Among those referred to physiotherapy with distal arm 
pain—that is, pain in the elbow, forearm, wrist or hand—
around 50% still report pain at 1 year, with a substantial 
minority reporting that symptoms are unremitting.7 Inter-
estingly, although conventional teaching would suggest that 
distal arm pain is caused by specific conditions (epicondy-
litis, tenosynovitis, de Quervain’s, carpal tunnel syndrome) 
or may be non-specific, there is little evidence of any differ-
ence in prognosis among these groups 1 year after physio-
therapy referral.7
Thus, the evidence suggests that distal arm pain is 
common, disabling and has mechanical and psychoso-
cial aetiology, and there is little evidence that separating 
states of ‘disease’ with different presumed causation or 
risk factors results in different therapeutic outcomes. 
In many respects, therefore, distal arm pain is similar to 
mechanical low back pain, the management of which was 
transformed when evidence emerged that bed rest was inef-
fective and that patients experienced improved outcomes 
if they maintained activities.8 Today, through education 
and large-scale health campaigns,9 practice has changed 
and unless there are red flags, few are sent for imaging, 
receive specific diagnoses or are advised to rest. In contrast, 
with the exception of specific treatments for certain under-
lying pathologies (eg, decompression for carpal tunnel 
syndrome), rest is the most prescribed recommendation in 
the management of distal arm pain, with the use of anal-
gesics or anti-inflammatories as required, and referral for 
physiotherapy for persistent symptoms. Guidance from the 
UK National Health Service (NHS) website recommends 
that for tendonitis and tennis elbow, it is important to rest 
the injured limb and stop doing the exercise or activity that 
caused the symptoms,10 11 and the UK Health and Safety 
Executive advises that ‘if a task is causing or contributing 
to an upper limb disorder, the worker may need to stop 
doing that task for a time’.12 This guidance is based on the 
biomedical assumption that the tissues have been ‘injured’, 
and that the treatment of choice is therefore avoidance, 
even though there is no published evidence to support this 
assumption.
Written information providing evidence-based advice 
(The Back Book) is effective in promoting positive beliefs 
and contributing to improved clinical outcomes in back 
pain.13 14 It is plausible therefore that patients with distal arm 
pain could benefit from a similar approach. We conducted a 
randomised controlled trial to test the hypothesis that, among 
patients referred for physiotherapy with an episode of distal 
arm pain, advice to remain active and maintain usual partici-
pation results in a long-term reduction in disability, compared 
with advice to rest. Within the same trial, we also tested the 
hypothesis that, among patients referred for physiotherapy 
with an episode of distal arm pain, fast-track treatment would 
result in reduced long-term disability, as compared with treat-
ment delivered after routine NHS waiting times.
MeTHOds
design
We conducted a multicentre, three-arm, randomised 
controlled trial. The study was registered on www. 
controlled- trials. com (reference: ISRCTN79085082) 
and its full protocol has been published.15 The study 
was approved by the UK South Central (Hampshire A) 
Research Ethics Committee (reference: 11/SC/0107).
Patients
Participants were recruited from 14 NHS primary care 
physiotherapy referral centres, across the UK. Patients 
(aged ≥18 years) were potentially eligible for study if 
they were newly referred for outpatient physiotherapy 
with distal arm pain or disability. They were excluded, 
however, if they had received physiotherapy for distal arm 
pain within the past twelve months; the distal arm was not 
the main focus for treatment (eg, the pain was thought to 
originate from pathology in the neck); the pain was due 
to a fracture, systemic inflammatory disease, cancer or 
complex regional pain syndrome; symptoms were due to 
a specific disorder for which advice to remain active was 
contraindicated (eg, florid tenosynovitis); the appoint-
ment was classed as an emergency and/or they were 
involved in a legal dispute regarding their arm problem.
Potential participants were identified from outpatient 
clinic referrals and sent an invitation letter by a local 
research nurse, followed by a reminder if they failed to 
respond. Those who indicated that they might be willing 
to participate were invited to attend a pretrial screening 
visit to confirm their eligibility. At the visit, patients 
completed a questionnaire that asked about demo-
graphic characteristics, employment, symptom history, 
disability caused by the arm problem and other factors 
thought to be important potential prognostic markers or 
modifiers of treatment response. These included general 
health, physical and mental well-being, other symptoms 
(headache/abdominal pain/chronic widespread pain), 
somatic distress and health beliefs (especially fear avoid-
ance). Patients also underwent a structured examination 
for the purposes of diagnosis and classification—the 
Southampton Examination Schedule for Upper Limb 
Disorders.16 This examination, involving inspection, 
palpation and clinical provocation tests, has previously 
been validated for outpatient and community settings 
and applied in large-scale epidemiological studies,17 and 
all research nurses were trained in the conduct of the 
examination by two of the investigators who originally 
developed and validated the examination schedule.
Consent
Patients provided written informed consent before 
completing the baseline (screening) questionnaire 
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and physical examination. They were also asked to give 
consent for randomisation should they prove to be 
eligible and this was reconfirmed, verbally, immediately 
prior to randomisation.
Randomisation
Randomisation was conducted by the Robertson Centre 
for Biostatistics, University of Glasgow (part of the UK 
Clinical Research Collaboration registered Clinical Trials 
Unit) and was performed online, with telephone backup. 
Patients were allocated to one of the three treatment 
groups, using a mixed randomisation and minimisation 
algorithm to maintain treatment balance with respect to 
treatment centre, laterality (dominant, non-dominant, 
bilateral), a broad categorisation of diagnosis (predom-
inant problem in the elbow vs wrist/hand) and baseline 
arm function, as assessed using a modified-Disabilities of 
the Arm, Shoulder and Hand (DASH) score (the primary 
outcome measure, see below, with scores grouped as 
0–5, 6–8, or 9–11). One-third of patients were allocated 
completely at random, while two-thirds were allocated 
according to the minimisation algorithm. Randomisation 
to the three groups, or entry to the minimisation proce-
dure, was determined according to a prespecified alloca-
tion schedule generated using the method of randomised 
permuted blocks of nine participants. Within the minimi-
sation algorithm, any ties between treatment groups (ie, 
where allocation to more than one group would provide 
an equally low level of imbalance) were resolved by 
assigning the patient at random to one of the tied treat-
ment groups. In terms of allocation concealment, as a 
consequence of their login permissions on the database, 
researchers from any one site were blind to data (and, 
thus, all randomisation information) from all other sites. 
Within each site, in order for an individual to guess which 
allocation was coming next, they would need to know the 
minimisation data for all previously allocated patients. 
Even then, they would be unable to determine whether 
the next patient was going to be allocated according to 
the minimisation algorithm or at random.
Treatment
Participants were randomised to one of the following:
a. Advice to remain active while awaiting usual care (wait-
ing list) physiotherapy.
b. Advice to rest while awaiting usual care (waiting list) 
physiotherapy.
c. Immediate physiotherapy.
Participants randomised to advice to remain active 
received a seven-page booklet on how to deal with arm 
pain: ‘Keep Active to Recover Quickly’.18 The booklet 
was biopsychosocial in nature and developed from the 
findings of a contemporary Health and Safety Executive 
Research Report.19 It presented the core message that 
distal arm pain is common, lasting damage is rare and 
that recovery can be expected. In addition, it advocated a 
self-management approach with advice that early return 
to work and gradually increasing activity is helpful. The 
booklet was given to participants immediately post-ran-
domisation, by the research nurse who conducted the 
screening/randomisation.
Participants randomised to advice to rest received a 
different booklet, designed to be similar in length and 
appearance. It was based on information available from 
the National Health Service at the start of the trial: 
‘Advice and Guidance on Arm Pain—Causes, Diagnosis, 
Treatment’.18 It adopted a firmly biomedical approach, 
advocating rest and avoidance of activities that might 
further aggravate symptoms.
Participants randomised to immediate physiotherapy 
received an outpatient appointment at their earliest 
convenience. The trial was intended to be pragmatic 
in the delivery of physiotherapy, insofar as it reflected 
usual clinical care. However, to ensure that treatment 
programmes were compliant with both the Medical 
Research Council’s and the Consolidated Standards 
of Reporting Trials organisation’s guidance on devel-
oping complex interventions, we conducted a review of 
national and international treatment guidelines to ascer-
tain current best practice. Therapists were presented 
with a summary of this review, but were able to treat 
patients on an individual basis with no restrictions on 
the number of appointments or treatment modalities. 
Thus, trial participation influenced when physiotherapy 
commenced, but not which specific therapeutic interven-
tions were delivered.
Patients who were allocated to either of the advice 
groups were subsequently invited to attend physiotherapy, 
as per usual care, after a normal interval on a waiting list. 
At the start of the trial, this wait was approximately 6-8 
weeks. Physiotherapists delivering their care received the 
same guidance on current best practice.
Outcomes
Reflecting a move away from pain as the primary outcome 
in many pain trials, and the concept that function is a 
more meaningful end point, the primary outcome was a 
complete absence of disability at 26-weeks postrandomi-
sation, as assessed using a modified version of the DASH 
questionnaire. The modified instrument was considered 
superior to the original for a number of reasons. For 
example, the original questionnaire contains no items 
that are specific to the distal arm, or that refer to activity 
limited specifically by pain. The modified instrument 
(mDASH) asked whether participants had experienced 
difficulty (yes/no/not applicable) with any of a list of 11 
activities over the past 7 days, because of an ‘ache or pain 
in the elbow, forearm, wrist or hand’ and has previously 
been used in large scale epidemiological studies of distal 
arm pain.7
The mDASH was assessed by postal questionnaire 26 
weeks after randomisation with postal reminders to 
non-responders. Outcome data were also collected, in 
the same manner, at 6 weeks and 13 weeks postrandomi-
sation. Participants who did not return a questionnaire 
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were contacted by telephone for verbal completion of the 
instrument.
Participants were also asked about behaviours and 
beliefs, so that the impact of advice could be assessed, 
and economic outcomes (costs associated with health-
care resource use including distal arm related hospital 
admissions, outpatient attendance and visits to/from 
relevant health professionals and health-related quality 
of life measured by EuroQol-5D and Short Form-12 ques-
tionnaires) were assessed.
sample size and statistical analysis
Previous studies have found that, among persons with 
distal arm pain receiving usual care (advice to rest, 
followed by physiotherapy), 51% reported being free of 
disability at 26 weeks.7 The current trial was powered on 
the assumption that, among participants who received 
advice to remain active followed by physiotherapy, this 
would increase to 70%. We required 148 subjects, per 
group, to detect this difference with 90% power at a 
5% level of significance. From our experience of trials 
in other pain conditions,20 we anticipated a 20% loss to 
follow-up and, thus, we aimed to assign 185 patients per 
group. In addition, we aimed to allocate a further 185 
patients to immediate physiotherapy, that is, a total of 555 
randomised participants.
The primary analysis determined, at 26 weeks postran-
domisation (1) whether participants who received advice 
to remain active were more likely to be free of disability, 
compared with those advised to rest and (2) whether 
those randomised to immediate physiotherapy were 
more likely to be free of disability, compared with those 
who received physiotherapy after a period on a waiting 
list. A mixed effects logistic regression model was used to 
estimate the OR for full recovery (mDASH=0) between 
different treatment groups. The model included treat-
ment group (as a three-level categorical variable), age, 
gender, study centre, pain location (elbow, wrist/hand or 
both), laterality (dominant, non-dominant or bilateral) 
and baseline function (mDASH: 0–5, 6–8 or 9–11). The 
method of recycled predictions was used to estimate the 
absolute difference in the probability of being fully recov-
ered between groups (advice to remain active vs advice to 
rest and immediate vs usually timed physiotherapy). The 
model used for the primary analysis was used to work out 
the predicted probability of the outcome for each indi-
vidual in the study, based on the baseline characteristics 
of the individual as well as treatment allocation. Thus, we 
estimated the probability of full recovery for each indi-
vidual in the study, under the assumption that all received 
a single treatment and compute the average (mean) 
predicted probability for the study population under this 
treatment. When repeated for each treatment group, this 
gives the overall probability of full recovery under each 
treatment (and the absolute differences between them). 
CIs were then computed using 1000 bootstrap samples.
All analyses were by intention-to-treat, and preplanned 
sensitivity analyses were conducted, making different 
assumptions about participants with missing data for the 
primary outcome: that all had fully recovered and that 
none had fully recovered.
A prespecified analysis was conducted to examine any 
evidence of heterogeneity of treatment effects, through 
the use of terms for interactions between treatment and 
each of the other variables in the regression models.15
Although the primary outcome treated the mDASH 
score dichotomously—that is, number of functional 
limitations at 26 weeks, none versus any—a preplanned 
secondary analysis considered the mDASH score as a 
continuous variable. A linear regression model was fitted, 
adjusting for the same factors as previously. This model 
was used to estimate the difference in mean mDASH 
scores between those randomised to receive advice to 
remain active and those advised to rest, and also those 
randomised to immediate physiotherapy and those 
randomised to usual care physiotherapy—for which the 
mean mDASH score was taken as the average of the two 
advice groups. Results were summarised as the mean 
differences in scores between the three treatment groups 
after adjustment for the covariates in the models.
Finally, we conducted a 26-week within-trial economic 
evaluation (cost-utility analysis, where benefits are 
measured in terms of quality-adjusted life years [QALYs]) 
from a UK health sector perspective. Assessments of the 
cost-effectiveness of alternative treatments are expressed 
as incremental cost-effectiveness ratios. Here, the health 
economic analysis will only be presented briefly, but full 
details of the economic evaluation methods and results 
are reported in a separate paper.21
ResulTs
Between February 2012 and February 2014, 1663 patients 
were invited to pretrial screening, of whom 680 were 
assessed for eligibility and 538 were randomised: 178 
to advice to remain active, 182 to advice to rest and 178 
advice to immediate physiotherapy; figure 1). The mean 
(SD) age of participants was 49 (14) years and 46% were 
male. Twenty-nine per cent of participants reported 
pain/disability in their elbow, 34% in their wrist/hand 
and 37% in both. According to the Southampton Exam-
ination Schedule, 67% had a specific disorder, while 
33% had non-specific symptoms. Lateral epicondylitis, 
tenosynovitis and thumb osteoarthritis made up nearly 
two-thirds of the specific diagnoses recorded (23%, 21%, 
and 17%, respectively).Table 1 shows the demographic 
and baseline characteristics of the randomised partici-
pants, by treatment group.
At 26 weeks, 81% of participants provided primary 
outcome data (figure 1) with similar proportions between 
treatment groups: 136 (76%), 146 (80%) and 152 (85%) 
in the advice to remain active, advice to rest and imme-
diate physiotherapy groups, respectively, of whom 60 
(44%), 46 (32%) and 53 (35%) reported full recovery. The 
figure 2 (panel A), illustrates the proportion of respon-
dents at each time point with no disability (mDASH=0). 
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Figure 1 Consolidated Standards of Reporting Trials flow diagram.
This increased from 3.3% at baseline to 37% at 26 weeks. 
The figure 2 (panel B) shows the prevalence of complete 
recovery in the three treatment groups at different stages 
of follow-up. Differences at 6 weeks and 13 weeks were 
small, but at 26 weeks, the probability of full recovery was 
45.1% among participants who received advice to remain 
active, compared with 32.2% among those who received 
advice to rest; a difference of 12.9% (95% CI 2.3% to 
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Table 1 Baseline characteristics
Selected baseline characteristics* 
Advice to remain active
(N=178)*
Advice to rest
(N=182)*
Immediate physiotherapy
(N=178)*
Age, mean (SD) 49.1 (13.9) years 50.3 (14.2) years 48.2 (12.8) years
Gender (male) 77 (43.3%) 87 (47.8%) 81 (45.5%)
Body mass index, mean (SD) 27.3 (5.04) kg/m2 27.5 (5.25) kg/m2 27.1 (4.47) kg/m2
Employment status 
  Full-time work 79 (44.4%) 94 (51.9%) 98 (55.4%)
  Part-time work 39 (21.9%) 28 (15.5%) 29 (16.4%)
  Retired 29 (16.3%) 31 (17.1%) 17 (9.6%)
  Other 31 (17.4%) 28 (15.5%) 33 (18.6%)
Handedness 
  Right 155 (87.1%) 154 (84.6%) 162 (91.0%)
  Left 18 (10.1%) 17 (9.3%) 13 (7.3%)
  Both 5 (2.8%) 11 (6.0%) 3 (1.7%)
Broad diagnosis 
  Elbow 50 (28.1%) 53 (29.1%) 53 (29.8%)
  Wrist/hand 61 (34.3%) 62 (34.1%) 58 (32.6%)
  Both 67 (37.6%) 67 (36.8%) 67 (37.6%)
Specific problem† 
  Specific 127 (74.7%) 107 (60.5%) 114 (66.3%)
  Non-specific 43 (25.3%) 70 (39.5%) 58 (33.7%)
Laterality of problem 
  Dominant 80 (44.9%) 83 (45.6%) 81 (45.5%)
  Non-dominant 54 (30.3%) 55 (30.2%) 52 (29.2%)
  Bilateral 44 (24.7%) 44 (24.2%) 45 (25.3%)
Duration of problem 
  ≤1 month 38 (22.2%) 38 (21.6%) 26 (15.2%)
  >1 month 133 (77.8%) 138 (78.4%) 145 (84.8%)
Pain severity, median (IQR)‡ 
  Right side 5 (1, 7) 5 (2, 7) 5 (2, 7)
  Left side 3 (0, 6) 3 (0, 6) 3 (0, 7)
Tampa Scale of Kinesiophobia, mean (SD) 3.62 (5.60) 3.67 (5.77) 3.63 (5.99)
Baseline mDASH‡ score, mean (SD) 5.9 (2.8) 5.8 (2.8) 5.9 (2.7)
EQ-5D health utility score, mean (SD) 0.674 (0.222) 0.667 (0.233) 0.655 (0.224)
*All data presented as N (%), unless otherwise specified.
†Numbers do not sum to randomised totals, due to missing data from clinical examination and, thus, an inability to classify all participants.
‡On how many days in the past 7 days did you have pain in your elbow, forearm, wrist or hand? (0–10 numerical rating scale).
EQ-5D, EuroQol 5D; mDASH, modified Disabilities of Arm Shoulder and Hand questionnaire.
23.7%) (table 2). This equates to an OR for full recovery 
at 26 weeks of 0.54 (95% CI 0.32 to 0.90) for advice to rest 
versus advice to remain active. In contrast, there was no 
significant difference in the probability of full recovery 
at 26 weeks between participants randomised to imme-
diate (35.8%) as compared with routinely timed physio-
therapy (38.6%), a difference of −2.8% (95% CI −11.3% 
to 6.5%). The adjusted OR for full recovery at 26 weeks 
was 0.64 (95% CI 0.39 to 1.07) for immediate physio-
therapy versus advice to remain active. Sensitivity analysis, 
making different (prespecified) assumptions about the 
prevalence of full recovery at 26 weeks and, separately, 
excluding participants who provided follow-up data by 
telephone, did not alter these conclusions (table 2).
There was no clear evidence of an effect in the early 
part (≤13 weeks) of the follow-up period from advice to 
remain active (figure 2). The differences in the probability 
of full recovery at 6 weeks and 13 weeks, in comparison 
with those who received advice to rest, were 0.3% (95% 
CI −6.4% to 6.8%) and 3.1% (95% CI −6.7% to 12.0%), 
respectively (table 3). Similarly, there was no evidence of 
short-term benefit from immediate physiotherapy versus 
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Figure 2 Proportion of responders with no disability, at each time point.
Table 2 Probability of full recovery at 26 weeks
Probability of full recovery at 26 weeks (95% CI)
Main analysis Sensitivity analysis* Sensitivity analysis† Sensitivity analysis‡
Advice to remain active 45.1% (37.3 to 53.0) 58.7% (51.9 to 66.0) 34.4% (27.7 to 41.5) 44.6% (34.1 to 54.8)
Advice to rest 32.2% (24.4 to 39.7) 45.6% (37.8 to 52.9) 25.2% (18.4 to 31.7) 23.7% (14.3 to 33.1)
Difference 12.9% (2.3 to 23.7) 13.1% (3.4 to 22.3) 9.2% (0.3 to 18.5) 21.0% (7.6 to 34.7)
Immediate physiotherapy 35.8% (28.7 to 42.9) 44.7% (37.8 to 51.4) 29.6% (23.1 to 36.2) 33.2% (24.8 to 42.7)
Normally timed physiotherapy 38.6% (32.8 to 44.2) 52.1% (46.7 to 57.7) 29.8% (24.3 to 34.8) 34.1% (26.9 to 41.3)
Difference −2.8% (−11.3 to 6.5) −7.5% (−16.1 to 0.7) −0.2% (−8.3 to 8.1) −0.9% (−11.9% to 10.4)
*Assumes all participants with missing data at 26 weeks were fully recovered.
†Assumes no participants with missing data at 26 weeks were fully recovered.
‡Restricting analysis to follow-up questionnaire respondents only.
usually timed treatment, differences in the probability 
of full recovery being −0.4% (95% CI −6.4% to 5.3%) 
and −1.6% (95% CI −9.5% to 5.9%) at 6 weeks and 13 
weeks, respectively. While patients were more than five 
times more likely to report full recovery at 26 weeks than 
6 weeks (OR 5.31; 95% CI 3.86 to 7.31) there was no 
evidence of a time-by-treatment interaction (p=0.750).
There were indications of a gender-by-treatment 
interaction (p=0.047) such that, compared with men 
randomised to advice to remain active, those randomised 
to either of the other two groups were less likely to report 
full recovery at 26 weeks, whereas this did not apply in 
women (figure 3). Although there were other minor 
differences between subgroups, there were no other 
large or statistically significant interactions between treat-
ment group and the other variables in the final model.
While the proportion of participants reporting full 
recovery at 26 weeks differed between treatment groups, 
no significant difference was observed in mean mDASH 
score between those who received advice to remain active 
and those advised to rest (−0.50; 95% CI −1.13 to 0.13) 
or between those who received immediate as compared 
with normally timed physiotherapy (0.24; 95% CI −0.29 
to 0.78).
Cost-effectiveness
The number of treatment sessions was similar between 
treatment groups (table 4), indeed the difference in mean 
NHS costs between the three groups was small and not 
statistically significant. Adjusted mean cost differences 
were £88 (95% CI −£14 to £201) for advice to remain 
active versus advice to rest and −£14 (95% CI −£87 to 
£66) for immediate versus normally timed physiotherapy 
(table 5). The differences in mean QALYs were also 
similar between treatment groups: adjusted mean QALY 
differences were 0.0095 (95% CI −0.0140 to 0.0344) for 
advice to remain active vs advice to rest and 0.0143 (95% 
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Table 3 Probability of full recovery, at 6 weeks and 13 
weeks
Probability of full recovery (95% CI)
6 weeks 13 weeks
Advice to remain 
active
10.4% (5.7 to 15.2) 22.8% (16.3 to 30.0)
Advice to rest 10.1% (5.0 to 15.3) 19.7% (13.0 to 26.3)
Difference 0.3% (−6.4 to 6.8) 3.1% (−6.7 to 12.0)
Immediate 
physiotherapy
9.8% (4.9 to 14.9) 19.6% (13.5 to 26.0)
Normally timed 
physiotherapy
10.3% (6.7 to 14.0) 21.2% (16.2 to 26.0)
Difference −0.4% (−6.4 to 5.3) −1.6% (−9.5 to 5.9)
Figure 3 Impact of treatment on full recovery at 26 weeks by gender.
Table 4 Number of physiotherapy treatment sessions, per 
group
Median IQR Range
Advice to remain active 3 2–4 1–14
Advice to rest 3 2–5 1–15
Immediate physiotherapy 3 2–5 1–12
CI −0.0077 to 0.0354) for −£14 (95% CI −£87 to £66) for 
immediate versus normally timed physiotherapy.
dIsCussIOn
Among patients referred to physiotherapy with distal 
arm pain, we have demonstrated that advice to remain 
active is associated with better functional recovery at 26 
weeks, compared with advice to rest. In addition, we have 
shown that physiotherapy delivered immediately offers 
no additional benefit in terms of disability at 26 weeks, 
compared with physiotherapy delivered after a 6–8 weeks 
waiting time.
Several methodological issues should be considered 
when interpreting these findings. First, we expected that 
approximately half of participants would be symptom-free 
after 26 weeks, based on a previous study of distal arm 
patients recruited from primary care and physiotherapy.7 
In fact, according to the primary outcome chosen for 
this study (complete absence of disability (mDASH=0) 
after 26 weeks), the proportion of patients in any of 
the three arms who had fully recovered was lower than 
50%. The original power calculation anticipated a 51% 
recovery rate in the group advised to rest. The primary 
analysis model predicted the recovery rate in this group 
to be 32.2%; thus, the original target of 148 per group 
had 90% power to detect an increase to 51.5%. This 
absolute increase in recovery of 19.3% is comparable 
to the original sample size calculation, which gave 90% 
power to detect an absolute increase in recovery of 19% 
(from 51% to 70%). Given the achieved sample size for 
the primary analysis (N=136 and N=146 in the active and 
rest groups, respectively), the study had 89% to detect an 
increase in recovery from 32.2% to 51.5%. Therefore, we 
do not believe that our study was underpowered to detect 
important differences between groups.
Second, although we conducted intention to treat anal-
ysis, it is important to note that primary outcome data 
could not be obtained for 19% of participants. Impor-
tantly, sensitivity analyses, which assumed both of the 
extreme scenarios—that all or none of those with missing 
data had fully recovered—indicated that the main trial 
results were not critically influenced by the unavailable 
data.
Although patients were potentially eligible if they were 
referred to physiotherapy with pain and/or disability in 
the distal arm, referral letters were not available, and it 
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Table 5 Mean overall costs and QALYS for the three treatment groups (over 26 weeks)
Mean (SD) 
NHS costs
Mean (SD) 
QALYs
Incremental mean 
costs (95% CI)*
Incremental mean 
QALYs (95% CI)* Mean ICER† (£/QALY)
Group1
Advice to remain 
active
£309.91 
(£321.45)
0.372 (0.111) −£87.87
(−£14.33 to £200.83)
0.0095
(−0.0140 to 0.0344)
Group 1 versus Group 2:
£9256
Group 2
Advice to rest
£223.15 
(£225.39)
0.366 (0.077) – – –
Group 3
Immediate 
physiotherapy
£221.46 
(£220.54)
0.388 (0.089) −£14.22
(−£87.14 to £66.01)
0.0143
(−0.0077 to 0.0354)
Group 3 versus Group 1 and 2
Group 3 dominant (cost per 
QALY gained <0)
*Adjusted for age, gender, work status, modified-DASH, EQ-5D health utility score and NHS cost and bootstrapped non-parametric 95% CI.
†Mean ICER, adjusted for age, gender, work status, modified-DASH, EQ-5D health utility score and NHS cost.
DASH, Disabilities of the Arm, Shoulder and Hand; EQ-5D, EuroQol-5D; ICER, incremental cost-effectiveness ratio; NHS, National Health 
Service; QALY, quality-adjusted life year.
is not known how many participants were referred with 
pain, disability or both. However, at the point of randomi-
sation, 458 (85%) reported pain and disability; 62 (12%) 
disability but no pain; 17 (3%) pain but no disability and 
one neither (but was randomised nonetheless, because 
the eligibility criteria applied at screening and initial 
invitation). Treatment allocation was similarly balanced 
between these four groups and, in the two groups 
reporting disability at baseline, the proportion achieving 
the primary outcome was comparable: 36% and 32%, 
respectively. Interestingly, of those without disability at 
baseline, around one-quarter had disability at 26 weeks.
Follow-up questionnaires were required at 6 weeks, 12 
weeks and 26 weeks. However, anticipating some non-re-
sponse, we also obtained ethical approval to contact 
non-responders (after a postal reminder) by telephone 
to collect more limited follow-up data. Our follow-up 
response rates were much as expected, but over 26 weeks, 
there was an increase in the proportion of responders 
who provided outcome data by telephone, with small 
(although non-significant) differences between groups 
(figure 1). Importantly, post hoc analysis, restricted to 
questionnaire respondents, revealed similar findings to 
the main analysis (table 2) and did not call into question 
the validity of conclusions based on the main analysis.
The prestated outcome was complete recovery from 
disability15 and with this outcome advice to remain active 
was clearly superior to advice to rest. However, when the 
mDASH was analysed as a continuous variable, the differ-
ence between the advice groups, although in the same 
direction, was not statistically significant (difference in 
mean mDASH score between active vs rest advice groups: 
−0.50 (95% CI −1.13 to 0.13). One can speculate the 
reasons for this, although it may be that mean values for 
the mDASH were strongly influenced by a small minority 
of participants with relatively high scores, making it 
harder to demonstrate statistical significance.
This study was predicated on the assumption that distal 
arm pain might be similar to mechanical low back pain—
both are common and disabling, have similar profiles of 
risk factors with little evidence that, among those referred 
for physiotherapy, separating different ‘diseases’ leads to 
any difference in prognosis.22 The superiority of avoiding 
rest in back pain management was first demonstrated 
>20 years ago, but rest continues to be widely advocated 
in the immediate management of distal arm pain under 
the beliefs of a biomechanical causation.10 11 Our results 
provide evidence that, among this group of patients, as 
for back pain, advice to rest may not be the best approach. 
The content of the experimental leaflet gave reassur-
ance, explained that often there is no obvious cause of 
injury, promoted the maintenance of activity and advised 
early return to work. Our study could not inform as to 
whether the advice leaflets were read or not. However, 
it is interesting to note that at 6 weeks postrandomisa-
tion, 50.5% of those in the ‘active’ advice group reported 
that they were trying to be more active than when their 
pain had first started, compared with only 29.9% of 
those advised to rest (difference: 20.6%; 95% CI 8.0% 
to 33.1%). This differential was maintained at 13 weeks 
(47% vs 32%), but was no longer apparent at 26 weeks 
(49% vs 45%). Although not conclusive, this is consistent 
with the hypothesis that the positive outcome seen at 26 
weeks was built on early changes in health behaviour 
and/or associated health beliefs. Alternatively, it may be 
that keeping active during the initial waiting list period 
enables participants to derive more benefit from physio-
therapy when they receive it. This would also explain the 
fact that the divergence in effect is seen at 13 weeks (ie, 
after advice and after physiotherapy). It would have been 
interesting to have objectively measured activity levels, 
but this was not feasible in the current study. It would be 
naive to assume that all participants adhered perfectly to 
the advice they were given. However, lack of adherence 
would tend to bias the findings towards the null hypoth-
esis, that is, more likely to find no differences between 
groups, and makes the fact that a difference was observed 
even more remarkable.
A small proportion of participants in the advice groups 
sought private physiotherapy to obtain treatment sooner 
than was available via the NHS. If the proportion of 
patients doing this was greater among those advised to 
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remain active, it might explain their better outcomes. 
However, a comparison showed that the rates of private 
physiotherapy were similar between advice groups (12% 
and 15%) and therefore unlikely to explain the findings. 
Additionally, in confirmatory analyses in which those who 
took up private physiotherapy were excluded, the trial 
results were unaltered.
Because physiotherapy regimens were not specified 
in the study protocol, it might be feasible that there had 
been some systematic differences in the treatment given 
between groups, perhaps in the number of sessions or 
the treatment modalities employed. However, these data 
were recorded throughout the trial and we found no 
differences in the median number of treatment sessions 
between groups. While the frequency of physiotherapy 
sessions varied depending on centre and therapist, most 
participants were treated once per week until discharge, 
as one would expect in usual care—reflecting the prag-
matic nature of the trial. A comparison of treatment 
modalities between those randomised to immediate or 
‘waiting list’ physiotherapy revealed that those in the 
‘immediate’ groups were more likely to receive Protec-
tion, Rest, Ice, Compression and Elevation (PRICE), but 
this is to be expected since PRICE is recommended in 
response to acute pain. Indeed, the ‘immediate’ group, 
possibly as part of ‘Protection’, were more likely to be 
given an orthotic device. In interpreting these data, 
however, there is no reason to expect that greater use of 
these modalities would detract from the benefits of early 
physiotherapy, and there were no other large, consistent, 
or statistically significant differences in treatment modal-
ities between any of the three groups. For all groups, 
education and exercise were the most commonly recom-
mended therapies.
Most participants had experienced symptoms for >1 
month before recruitment. It is perhaps not surprising, 
therefore, that differences between the two advice groups 
did not emerge immediately, but rather were gradual, 
and only statistically significant at 26 weeks (the prespec-
ified primary end point). Although the difference was 
not great, a slightly smaller proportion of patients in 
the immediate group presented with a short duration of 
symptoms (≤1 month): 15% versus 22% in each of the 
advice groups, but, symptom duration was not associated 
with prognosis. We also found no evidence of hetero-
geneity of the effect of advice to remain active between 
participants with a specific versus non-specific diagnosis. 
This supports previous epidemiological work suggesting 
no difference in prognosis between those with specific/
non-specific symptoms.7
The interaction between gender and treatment is 
intriguing. This (prespecified) analysis was conducted 
to determine whether there was any evidence of hetero-
geneity of treatment effect between treatment group 
and other variables in the final regression model, rather 
than because of any particular a priori clinical hypoth-
esis. Women, at baseline, reported higher levels of 
disability than men and the probability of full recovery 
was inversely proportional to baseline disability. It may 
be, therefore, that it was simply harder for them to reach 
full recovery after 26 weeks than it was for men. However, 
the explanation for this finding cannot be determined 
from the available data.
In summary, pain and disability in the distal arm 
is common. Although aetiological and prognostic 
factors are similar to those for low back pain, hitherto, 
its management has been very different. Rest is rarely 
advised for back pain but is commonly recommended 
for patients with distal arm pain, despite the lack of any 
published evidence to support this management strategy. 
Our trial calls this approach into question and provides 
the first evidence that advice to remain active is associated 
with superior clinical outcomes. Furthermore, we found 
no indication that earlier initiation of physiotherapy 
improved long-term clinical outcome. This has important 
implications for employers and their occupational health 
advisors, as well as for those working in primary care 
and physiotherapy. Although immediate physiotherapy 
was shown to be no more effective than physiotherapy 
delivered after a waiting list, it was no more costly. What 
is clear, however, is that the early management should 
encourage activity: this is more effective, in terms of 6 
month outcome, and also more likely to be cost-effective 
than advice to rest. Undoubtedly, further independent 
confirmation would strengthen our conclusions but there 
is unlikely to be additional randomised controlled trial 
data available. Therefore, based on the previous epide-
miological data, an extensive evidence base about back 
pain, and from the current trial results, we recommend 
that, for the majority of cases, the most sensible course of 
action would be to stop advising that patients with distal 
arm pain rest, while awaiting physiotherapy.
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